{"text_format":"2","workbook":"xlsx","n_sheets":1,"sheets":["LFA Spot Checklist-Copaid ACTs"],"not_rendered":{"charts":0,"images":1,"macros":0,"external_links":0,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"LFA Spot Checklist-Copaid ACTs","index":0,"n_rows":40,"n_cols":5,"rows_kept":40,"cut":false,"hidden":false,"merged":[[34,1,34,3],[35,1,35,3],[1,1,1,4],[2,1,2,4],[3,1,3,4],[4,1,4,4]]}
[{"$nulls":4},"August 2014"]
["Country"]
["Grant number"]
["Principal Recipient"]
["Name of First-Line Buyer"]
[]
["First-Line Buyer registration","NA","Yes","No","Comments"]
["Valid licence/autorisation from national authorities to import/sell/distribute pharmaceutical products?"]
["If the registration is time-limited, when does it end?"]
["Diversion, monotherapies and hospital/individual packs","NA","Yes","No","Comments"]
["Was a customers list for co-paid ACTs in the last two years made available?"]
["Do you have reasons to suspect co-paid ACTs were sold outside the AMFm country?"]
["Please provide reasons for your conclusion that co-paid ACTs were sold outside the Host Country."]
["Are there indications that co-paid ACTs were sold to unregistered buyers?"]
["Please provide the names and details of Second Line Buyers, if it is the case."]
["Are oral artemisinin monotherapies being sold?"]
["Please specify if oral artemisinin monotherapies have been purchased since the introduction of co-paid ACTs."]
["Are hospital packs sold to non clinical, hospital, health centers settings?"]
["Please provide reasons, if it is the case."]
["ACTm logo","NA","Yes","No","Comments"]
["Do co-paid ACTs sold by the First-Line Buyer bear the ACTm-leaf logo?"]
["Does the First-Line Buyer use promotional material showing the ACTm-leaf logo?"]
["If yes, did s/he sign a logo sub-license agreement with the licence holder in the country?"]
["Storage conditions","NA","Yes","No","Comments"]
["Was the stock register showing the movement and balances for co-paid ACTs made available?"]
["Was/were the warehouse(s) visited by the LFA?"]
["Are the storage conditions compatible with storage of drugs (cleanless, temperature, humidity)?"]
["Please note comments on the First-Line Buyer's storage conditions."]
["Reasonable margin","NA","Yes","No","Comments"]
["Was a price list per type of product/packaging made available?"]
["Co-paid ACT purchase price (USD/euros) per pack size ","attach a list"]
["Co-paid ACT sales price (local currency/USD/euros) per pack size ","attach a list"]
["Does the First-Line Buyer have a malaria product on sale with a similar purchase price like co-paid ACTs?"]
["What are the names and formulations of the products?"]
["What are the purchase and sales prices per pack size of these products?","Purchase (local currency/USD/euros):"]
[null,"Sales (local currency/USD/euros):"]
["What margin is applied on these products?"]
[" In your opinion (considering market conditions) was a reasonable margin applied to each co-paid ACT pack size?"]
["Other items as per country-specific First-Line Buyer Agreement signed with Principal Recipient","NA","Yes","No","Comments"]
["To be specified"]